000 01390 a2200337 4500
005 20250511210954.0
264 0 _c19910906
008 199109s 0 0 eng d
022 _a0272-6386
024 7 _a10.1016/s0272-6386(12)80888-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRaniele, D P
245 0 0 _aShould intravenous immunoglobulin G be first-line treatment for acute thrombotic thrombocytopenic purpura? Case report and review of the literature.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_cAug 1991
300 _a264-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aAcute Disease
650 0 4 _aAdult
650 0 4 _aCombined Modality Therapy
650 0 4 _aCosts and Cost Analysis
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xadministration & dosage
650 0 4 _aInfusions, Intravenous
650 0 4 _aMale
650 0 4 _aPlasmapheresis
_xeconomics
650 0 4 _aPurpura, Thrombotic Thrombocytopenic
_xeconomics
700 1 _aOpsahl, J A
700 1 _aKjellstrand, C M
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 18
_gno. 2
_gp. 264-8
856 4 0 _uhttps://doi.org/10.1016/s0272-6386(12)80888-2
_zAvailable from publisher's website
999 _c1873387
_d1873387